MoneyWorks4Me

Guj. Inject (Kerala) - Quaterly Results

16 Jul 2026 Evaluate
An increase of about 414.46% to Rs. 124.55 millions in the total revenue was observed for the quarter ended June 2026. The total revenue was pegged at Rs. 24.21 millions during the similar quarter previous year.The company almost doubled its revenue to Rs. 12.52 millions  from Rs. 0.72 millions in the quarter ended June 2026.The company reported a good operating profit of 16.88 millions compared to 0.97 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 124.55 24.21 414.46 124.55 24.21 414.46 363.20 190.46 90.70
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 1.96 1.80 8.89
PBIDT 16.88 0.97 1640.21 16.88 0.97 1640.21 25.05 12.55 99.60
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 -100.00
PBDT 16.88 0.97 1640.21 16.88 0.97 1640.21 25.05 12.53 99.92
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 16.88 0.97 1640.21 16.88 0.97 1640.21 25.05 12.53 99.92
TAX 4.36 0.25 1644.00 4.36 0.25 1644.00 6.90 2.37 191.14
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 12.52 0.72 1638.89 12.52 0.72 1638.89 18.15 10.16 78.64
Equity 146.35 146.35 0.00 146.35 146.35 0.00 146.35 146.35 0.00
PBIDTM(%) 13.55 4.01 238.26 13.55 4.01 238.26 6.90 6.59 4.67
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..